Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.36 |
| ▸ | SPHK1 | Q9NYA1 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 4/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29555015 | 0.87 | GBA1 (0.36) | GAAGBA1 | |
| SCHEMBL2591346 | 0.86 | OGA (0.33) | SPHK2SPHK1GAAGBA1 | |
| SCHEMBL5551957 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL22409570 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL9309804 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL25366499 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL9699515 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL19326770 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL19326781 | 0.84 | GAA (0.37) | GAA | |
| SCHEMBL2381492 | 0.84 | GAA (0.37) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020058795-A1 | HYDROPHOBIC GLYCOSYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR USE | VALENTIS, INC. | 2002-05-16 | — | — | US | disclosed |
| EP-1015465-A2 | HYDROPHOBIC GLYCOSYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR USE | Valentis Inc. (US) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999012945-A2 | HYDROPHOBIC GLYCOSYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR USE | VALENTIS,INC. (US) | 1999-03-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020058795-A1 | HYDROPHOBIC GLYCOSYLAMINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR USE | FUT5, FUT6, CSGALNACT1 | SPHK2 1380/4885SPHK1 1489/4885GAA 164/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.